Search Results

2021 Report on TGF Beta Receptor Type 2 Drugs in Development - Featuring Auxagen, InteRNA Technologies and Velvio Among Others

• Source: M2PressWIRE. 06/21/2021.

Record details

AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

• Authors : PR Newswire

Subjects: Maryland; Illinois; China

• Source: PR Newswire US. 04/25/2024.

Record details

New target discovered for treating myeloid leukemia.

• Source: Nation (Pakistan). 05/21/2021.

Record details

Advances in Transforming Growth Factor-β Signaling

• Authors : PR Newswire

Subjects: District of Columbia; Washington

• Source: PR Newswire US. 02/17/2021.

Record details

A Father's Hunt For His Daughter's Genetic Defect.

• Authors : Scott Simon; Hugh Rienhoff

• Source: Weekend Edition Saturday (NPR). 07/13/2013.

Record details

Kanazawa University research: Genetic switches in tumor development

• Authors : PR Newswire

Subjects: Japan; United States of America; United Kingdom

• Source: PR Newswire US. 11/09/2023.

Record details

Keros Therapeutics Inc to Host a Corporate Update Call - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 06/17/2024.

Record details

MAX BioPharma Announces Key Update to its Liver Fibrosis Program Showing Efficacy of an Oxysterol Lead Drug Candidate in Inhibiting NASH in a Humanized Mouse Model

• Authors : PR Newswire

Subjects: California

• Source: PR Newswire US. 03/03/2020.

Record details

Pliant Therapeutics Presents Data in Human NASH Liver Tissue at The International Liver Congress 2019 Hosted by the European Association for the Study of the Liver (EASL)

• Authors : PR Newswire

Subjects: California

• Source: PR Newswire US. 03/28/2019.

Record details

Q4 2023 aTyr Pharma Inc Earnings Call - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 03/14/2024.

Record details